Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug 13;19(1):159.
doi: 10.1186/s12911-019-0888-7.

The effect of ICU-tailored drug-drug interaction alerts on medication prescribing and monitoring: protocol for a cluster randomized stepped-wedge trial

T Bakker  1 , J E Klopotowska  2 , S Eslami  2   3 , D W de Lange  4 , R van Marum  5   6 , H van der Sijs  7 , E de Jonge  8 , D A Dongelmans  9 , N F de Keizer  2 , A Abu-Hanna  2
Affiliations

The effect of ICU-tailored drug-drug interaction alerts on medication prescribing and monitoring: protocol for a cluster randomized stepped-wedge trial

T Bakker et al. BMC Med Inform Decis Mak. .

Abstract

Background: Drug-drug interactions (DDIs) can cause patient harm. Between 46 and 90% of patients admitted to the Intensive Care Unit (ICU) are exposed to potential DDIs (pDDIs). This rate is twice as high as patients on general wards. Clinical decision support systems (CDSSs) have shown their potential to prevent pDDIs. However, the literature shows that there is considerable room for improvement of CDSSs, in particular by increasing the clinical relevance of the pDDI alerts they generate and thereby reducing alert fatigue. However, consensus on which pDDIs are clinically relevant in the ICU setting is lacking. The primary aim of this study is to evaluate the effect of alerts based on only clinically relevant interactions for the ICU setting on the prevention of pDDIs among Dutch ICUs.

Methods: To define the clinically relevant pDDIs, we will follow a rigorous two-step Delphi procedure in which a national expert panel will assess which pDDIs are perceived clinically relevant for the Dutch ICU setting. The intervention is the CDSS that generates alerts based on the clinically relevant pDDIs. The intervention will be evaluated in a stepped-wedge trial. A total of 12 Dutch adult ICUs using the same patient data management system, in which the CDSS will operate, were invited to participate in the trial. Of the 12 ICUs, 9 agreed to participate and will be enrolled in the trial. Our primary outcome measure is the incidence of clinically relevant pDDIs per 1000 medication administrations.

Discussion: This study will identify pDDIs relevant for the ICU setting. It will also enhance our understanding of the effectiveness of alerts confined to clinically relevant pDDIs. Both of these contributions can facilitate the successful implementation of CDSSs in the ICU and in other domains as well.

Trial registration: Nederlands Trial register Identifier: NL6762 . Registered November 26, 2018.

Keywords: Alert fatigue; Computerized decision support systems; Drug-drug interactions; Intensive care; Stepped-wedge trial.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Adapted version Reason’s model of accident causation applied to drug safety alerting from van der Sijs et al. (with permission) [16, 20]
Fig. 2
Fig. 2
Timeline of different components of this study
Fig. 3
Fig. 3
Timeline of stepped-wedge trial
See this image and copyright information in PMC

References

    1. Krahenbuhl-Melcher A, Schlienger R, Lampert M, Haschke M, Drewe J, Krahenbuhl S. Drug-related problems in hospitals: a review of the recent literature. Drug Saf. 2007;30(5):379–407. doi: 10.2165/00002018-200730050-00003. - DOI - PubMed
    1. Reis AM, Cassiani SH. Adverse drug events in an intensive care unit of a university hospital. Eur J Clin Pharmacol. 2011;67(6):625–632. doi: 10.1007/s00228-010-0987-y. - DOI - PubMed
    1. Kane-Gill SL, Dasta JF, Buckley MS, Devabhakthuni S, Liu M, Cohen H, et al. Clinical practice guideline: safe medication use in the ICU. Crit Care Med. 2017;45(9):e877–e915. doi: 10.1097/CCM.0000000000002533. - DOI - PubMed
    1. Hennessy S, Leonard CE, Gagne JJ, Flory JH, Han X, Brensinger CM, et al. Pharmacoepidemiologic methods for studying the health effects of drug-drug interactions. Clin Pharmacol Ther. 2016;99(1):92–100. doi: 10.1002/cpt.277. - DOI - PMC - PubMed
    1. Zheng WY, Richardson LC, Li L, Day RO, Westbrook JI, Baysari MT. Drug-drug interactions and their harmful effects in hospitalised patients: a systematic review and meta-analysis. Eur J Clin Pharmacol. 2018;74(1):15–27. doi: 10.1007/s00228-017-2357-5. - DOI - PubMed

Publication types

Associated data